Phase II study of Gleevec® plus hydroxyurea (HU) in adults with progressive or recurrent meningioma

Phase II study of subcutaneous octreotide in adults with recurrent or progressive meningioma and meningeal hemangiopericytoma

(2011) D. R. Johnson et al.   NEURO-ONCOLOGY

Intracranial meningiomas of atypical (WHO grade II) histology

(2010) Leland Rogers et al.   JOURNAL OF NEURO-ONCOLOGY

A review of malignant meningiomas: diagnosis, characteristics, and treatment

(2010) Simon Hanft et al.   JOURNAL OF NEURO-ONCOLOGY

Aberrant signaling pathways in meningiomas

(2010) Brian T. Ragel et al.   JOURNAL OF NEURO-ONCOLOGY

Pathological classification and molecular genetics of meningiomas

(2010) Christian Mawrin et al.   JOURNAL OF NEURO-ONCOLOGY

Phase II trials of erlotinib or gefitinib in patients with recurrent meningioma

(2009) Andrew D. Norden et al.   JOURNAL OF NEURO-ONCOLOGY

Phase II study of imatinib mesylate for recurrent meningiomas (North American Brain Tumor Consortium study 01-08)

(2009) Patrick Y. Wen et al.   NEURO-ONCOLOGY

LONG-TERM RECURRENCE RATES OF ATYPICAL MENINGIOMAS AFTER GROSS TOTAL RESECTION WITH OR WITHOUT POSTOPERATIVE ADJUVANT RADIATION

(2009) Manish K. Aghi et al.   NEUROSURGERY

Interferon-α for recurrent World Health Organization grade 1 intracranial meningiomas

(2008) Marc C. Chamberlain et al.   CANCER